Citigroup Inc Immunocore Holdings PLC Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Citigroup Inc holds 632,944 shares of IMCR stock, worth $18.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
632,944
Previous 16,032
3848.0%
Holding current value
$18.8 Million
Previous $499,000
3641.68%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IMCR
# of Institutions
125Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$199 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$197 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$145 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$79.4 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$65.1 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.31B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...